Insider signals. Catalyst calendar. AI-generated context. One dashboard, one weekly digest.
$29/mo after trial · Cancel anytime · No credit card to start
15
Specialist Funds
tracked quarterly
843+
Biotech Companies
cross-referenced
465+
Active Catalysts
PDUFAs, Phase 2/3
$73.4B
Tracked Positions
in fund holdings
Funds we track
Raw filings are noise. Context is edge.
Real signals from SEC filings, updated daily.
13F fund holdings, Form 4 insider trades, 13D/G activist stakes, and ClinicalTrials.gov catalyst data — parsed and normalized.
Routine option exercises and 10b5-1 plan trades get flagged. Every real signal gets analyst-grade context from AI.
Check your dashboard or read the Monday email digest. No more digging through EDGAR filings yourself.
SEC filings, clinical trial data, and insider transactions — with AI context so you can act faster.
Monitor positions from specialist biotech hedge funds. New positions, increases, trims, exits — with full portfolio drill-down.
See when 3+ specialist funds independently build positions in the same company. The highest-conviction signal in biotech.
Every signal includes AI context: catalyst timing, cash runway, dilution risk, and convergence signals.
PDUFAs, Phase 2/3 readouts, and advisory committees from ClinicalTrials.gov. Never miss a binary event.
10-Q-derived burn rates and runway estimates. Know which companies need to raise before their next catalyst.
Star any ticker, get email alerts when funds take positions, insiders trade, or catalysts update.
Built on SEC EDGAR filings, ClinicalTrials.gov data, and FDA calendar events. Updated daily. Contextualized by AI.
One plan. Full access. Cancel anytime.
7-day free trial included
No credit card required to start
All data is sourced directly from SEC EDGAR filings (13F, Form 4, 13D/13G), ClinicalTrials.gov for catalyst events, and FDA calendar dates. We parse and normalize the raw filings automatically.
Form 4 insider signals and 13D/G activist stakes are ingested daily. 13F fund positions are updated quarterly as funds file. Catalyst data is refreshed weekly from ClinicalTrials.gov.
We track 15 specialist biotech hedge funds including Baker Brothers, Perceptive Advisors, OrbiMed, RA Capital, and more. These are funds with deep biotech expertise and concentrated portfolios.
BiotechEdge focuses on the insight layer, not raw data. We combine 13F positions with insider signals, catalyst timing, and AI-generated context — so you understand why a position matters, not just that it exists.
Yes. Cancel from your dashboard at any time. No contracts, no commitments. Your access continues through the end of your billing period.
The AI context is generated from structured data — SEC filings, clinical trial records, and financial metrics. It summarizes what the data shows, not predictions. Think of it as having an analyst read every filing for you and write a 2-sentence brief.
When 3 or more specialist biotech funds independently build positions in the same company, it signals high institutional conviction. We surface this automatically — no manual cross-referencing across fund filings.
Join investors who track smart money moves before they show up in the news.
Start 7-Day Free Trial$29/mo after trial · Cancel anytime
Not ready to commit? Get the free weekly brief: